These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26275214)

  • 1. Monoclonal Antibodies Targeting the Alpha-Exosite of Botulinum Neurotoxin Serotype/A Inhibit Catalytic Activity.
    Fan Y; Geren IN; Dong J; Lou J; Wen W; Conrad F; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    PLoS One; 2015; 10(8):e0135306. PubMed ID: 26275214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal Antibodies that Inhibit the Proteolytic Activity of Botulinum Neurotoxin Serotype/B.
    Fan Y; Dong J; Lou J; Wen W; Conrad F; Geren IN; Garcia-Rodriguez C; Smith TJ; Smith LA; Ho M; Pires-Alves M; Wilson BA; Marks JD
    Toxins (Basel); 2015 Aug; 7(9):3405-23. PubMed ID: 26343720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
    Fan Y; Garcia-Rodriguez C; Lou J; Wen W; Conrad F; Zhai W; Smith TJ; Smith LA; Marks JD
    PLoS One; 2017; 12(3):e0174187. PubMed ID: 28323873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-domain llama antibody potently inhibits the enzymatic activity of botulinum neurotoxin by binding to the non-catalytic alpha-exosite binding region.
    Dong J; Thompson AA; Fan Y; Lou J; Conrad F; Ho M; Pires-Alves M; Wilson BA; Stevens RC; Marks JD
    J Mol Biol; 2010 Apr; 397(4):1106-18. PubMed ID: 20138889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
    Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
    J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
    Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
    J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Three-Monoclonal Antibody Combination Potently Neutralizes BoNT/G Toxin in Mice.
    Fan Y; Lou J; Tam CC; Wen W; Conrad F; Leal da Silva Alves P; Cheng LW; Garcia-Rodriguez C; Farr-Jones S; Marks JD
    Toxins (Basel); 2023 Apr; 15(5):. PubMed ID: 37235351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
    Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
    Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
    Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
    MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Three Monoclonal Antibody Combination Potently Neutralizes Multiple Botulinum Neurotoxin Serotype E Subtypes.
    Garcia-Rodriguez C; Razai A; Geren IN; Lou J; Conrad F; Wen WH; Farr-Jones S; Smith TJ; Brown JL; Skerry JC; Smith LA; Marks JD
    Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29494481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
    Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
    MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the monoclonal antibody response to botulinum neurotoxin type A in the complexed and uncomplexed forms.
    Zhao H; Nakamura K; Kohda T; Mukamoto M; Kozaki S
    Jpn J Infect Dis; 2012; 65(2):138-45. PubMed ID: 22446121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of enhanced neutralization of botulinum neurotoxin by monoclonal antibodies conjugated to antibodies specific for the erythrocyte complement receptor.
    Sharma R; Zhao H; Al-Saleem FH; Ubaid AS; Puligedda RD; Segan AT; Lindorfer MA; Bermudez R; Elias M; Adekar SP; Simpson LL; Taylor RP; Dessain SK
    Mol Immunol; 2014 Feb; 57(2):247-54. PubMed ID: 24184879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Compounds and Their Analogues as Potent Antidotes against the Most Poisonous Bacterial Toxin.
    Patel KB; Cai S; Adler M; Singh BK; Parmar VS; Singh BR
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30389764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.
    Kalb SR; Santana WI; Geren IN; Garcia-Rodriguez C; Lou J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
    BMC Biochem; 2011 Nov; 12():58. PubMed ID: 22085466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
    Scotcher MC; McGarvey JA; Johnson EA; Stanker LH
    PLoS One; 2009; 4(3):e4924. PubMed ID: 19290051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
    Shi DY; Lu JS; Mao YY; Liu FJ; Wang R; Du P; Yu S; Yu YZ; Yang ZX
    Appl Microbiol Biotechnol; 2023 May; 107(10):3205-3216. PubMed ID: 37058230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extraction and inhibition of enzymatic activity of botulinum neurotoxins/A1, /A2, and /A3 by a panel of monoclonal anti-BoNT/A antibodies.
    Kalb SR; Lou J; Garcia-Rodriguez C; Geren IN; Smith TJ; Moura H; Marks JD; Smith LA; Pirkle JL; Barr JR
    PLoS One; 2009; 4(4):e5355. PubMed ID: 19399171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model.
    Tomic MT; Farr-Jones S; Syar ES; Niemuth N; Kobs D; Hackett MJ; Espinoza Y; Martinez Z; Pham K; Snow DM; Marks JD; Cobb RR
    Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.
    Meng Q; Garcia-Rodriguez C; Manzanarez G; Silberg MA; Conrad F; Bettencourt J; Pan X; Breece T; To R; Li M; Lee D; Thorner L; Tomic MT; Marks JD
    Anal Biochem; 2012 Nov; 430(2):141-50. PubMed ID: 22922799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.